A review of PARP inhibitors: from bench to bedside

Annals of Oncology : Official Journal of the European Society for Medical Oncology
C UnderhillH Bonnefoi

Abstract

Poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors, with novel and selective mechanisms of action, have moved from the laboratory to the clinic in just the last few years. We conducted an extensive review of PARP inhibitors using a Medline search. We also searched abstracts in databases of major international oncology meetings from the last 4 years. To understand the mechanisms of action of PARP inhibitors requires a basic understanding of DNA repair mechanisms and the critical role of the PARP enzyme. We briefly review these DNA repair mechanisms, the concept of 'synthetic lethality', and how PARP inhibitors play a role to selectively disrupt DNA repair in cells with absent or dysfunctional BRCA genes. We review the preclinical data highlighting this unique and selective mechanism of action and we discuss early but highly promising clinical data and ongoing studies. PARP inhibitors show promise as a powerful therapeutic tool, especially in the management of BRCA-associated breast and ovarian cancers but also in tumours where BRCA genes may be dysfunctional. Clinical studies are ongoing and many translational questions remain unanswered that will help clarify how to determine the best way to use PARP inhibitors.

References

Oct 1, 1995·Trends in Biochemical Sciences·T LindahlA Klungland
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·J M de MurciaG de Murcia
Jul 14, 1998·Molecular Cell·K J PatelA R Venkitaraman
Aug 24, 1999·The Biochemical Journal·D D'AmoursG G Poirier
Feb 24, 2000·Gynecologic Oncology·W ZhengM C Pike
Jul 18, 2000·International Journal of Cancer. Journal International Du Cancer·P A RussellS A Gayther
Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Feb 24, 2001·The New England Journal of Medicine·I HedenfalkG Sauter
Apr 3, 2001·Nature Medicine·S R LakhaniA Ashworth
May 18, 2001·Nature·J H Hoeijmakers
Jul 4, 2002·Journal of the National Cancer Institute·Amir A JazaeriEdison T Liu
Dec 10, 2002·Trends in Molecular Medicine·Andrew Tutt, Alan Ashworth
Apr 15, 2003·Nature Medicine·Toshiyasu TaniguchiAlan D D'Andrea
May 3, 2003·The EMBO Journal·Josiane Ménissier de MurciaGilbert de Murcia
Jun 6, 2003·The New England Journal of Medicine·Richard Wooster, Barbara L Weber
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Jul 18, 2003·BMC Cell Biology·Georges NoëlVincent Favaudon
Aug 22, 2003·Nucleic Acids Research·Niklas SchultzThomas Helleday
Apr 2, 1963·Biochemical and Biophysical Research Communications·P CHAMBONP MANDEL
Sep 23, 2003·Nucleic Acids Research·Sherif F El-KhamisyKeith W Caldecott
Oct 2, 2003·Journal of the National Cancer Institute·William D FoulkesLars A Akslen
Jan 8, 2004·Journal of the National Cancer Institute·Christopher R CalabreseNicola J Curtin
Jan 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Anthony ChalmersBrian Marples
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monika E HegiRoger Stupp
Jul 27, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jean-Christophe AméGilbert de Murcia
Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth
Nov 18, 2004·Journal of the National Cancer Institute·Richard D KennedyD Paul Harkin
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Sep 2, 2005·The New England Journal of Medicine·Lawrence C Brody
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M ThrallJulie A DeLoia
Sep 26, 2006·Oncogene·N C Turner, J S Reis-Filho
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark Rosenthal
Apr 7, 2007·Mutagenesis·Filipe V Jacinto, Manel Esteller
Sep 28, 2007·Anti-cancer Agents in Medicinal Chemistry·Tomasz Zaremba, Nicola Jane Curtin

❮ Previous
Next ❯

Citations

Jan 30, 2013·Molecular Aspects of Medicine·W Lee Kraus, Michael O Hottiger
Oct 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S De SummaS Tommasi
Mar 7, 2012·Genes & Development·Xin Luo, W Lee Kraus
Jun 30, 2012·The American Journal of Chinese Medicine·Guosheng WuYitao Wang
Aug 9, 2011·Hereditary Cancer in Clinical Practice·Evgeny N Imyanitov, Vladimir M Moiseyenko
Mar 13, 2014·PLoS Biology·Zubaidah M RamdzanAlain Nepveu
May 6, 2011·The Oncologist·Thehang LuuGeorge Somlo
Jun 8, 2012·The Oncologist·Georgios Rigakos, Evangelia Razis
Feb 11, 2014·Nucleic Acids Research·Karolin LégerMichael O Hottiger
May 11, 2012·Future Medicinal Chemistry·Máximo de la VegaRicardo H Alvarez
Nov 5, 2013·Antioxidants & Redox Signaling·Wil L Santivasi, Fen Xia
Jun 21, 2014·Future Oncology·Mark R KelleyMelissa L Fishel
Jul 2, 2011·Chinese Journal of Cancer·Alice Chen
Nov 14, 2013·Molecular Cancer Therapeutics·Deanna M JanzenSanaz Memarzadeh
Sep 27, 2012·Neurochemical Research·Marina ScaliaVittoria Spina-Purrello
Apr 27, 2013·Archives of Gynecology and Obstetrics·Ying ChenQuan Hao
Jan 23, 2016·Future Oncology·Lucia Nappi, Martin E Gleave
Nov 28, 2014·International Journal of Molecular Sciences·Katarzyna M TerlikowskaSlawomir J Terlikowski
Jan 11, 2012·Expert Opinion on Investigational Drugs·Giuseppe CuriglianoAron Goldhirsch
Jan 15, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Annemiek M van MaldegemHans Gelderblom
Dec 5, 2012·Cancer Treatment Reviews·M Maugeri-SaccàR De Maria
Nov 29, 2011·Cancer Treatment Reviews·Jean-Charles SoriaPasi A Jänne
Jun 21, 2014·Neoplasia : an International Journal for Oncology Research·Khong-Loon TiongGrace S Shieh
Jul 9, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·E RassB-S Lopez
Jul 19, 2011·Cancer Treatment Reviews·Giuseppe Curigliano
Mar 2, 2012·International Journal of Cancer. Journal International Du Cancer·Rebeka SultanaSrinivasan Madhusudan
Apr 23, 2013·The FEBS Journal·Torun EkbladAntonio Macchiarulo
Jun 27, 2015·Medicinal Research Reviews·Ladislava Vymětalová, Vladimír Kryštof
Nov 21, 2015·Cell Reports·Stella Suyong LeeCarol Widney Greider
Jan 22, 2015·Hereditary Cancer in Clinical Practice·Maheen AnwarShahzad Anwar
Sep 3, 2011·Free Radical Biology & Medicine·Partha MukhopadhyayPál Pacher
Dec 14, 2011·Gynecologic Oncology·Robert A Burger
Dec 3, 2014·Nucleic Acids Research·Mareike LehmannMichael O Hottiger
Apr 24, 2014·Diabetes·Kristoffer Svensson, Christoph Handschin
Jul 9, 2016·International Journal of Cancer. Journal International Du Cancer·Mina NikanjamRazelle Kurzrock
Jul 30, 2016·Applied Microbiology and Biotechnology·K Hemalatha, G Madhumitha
Sep 20, 2016·BioMed Research International·Stephen MurataEun-Kyoung Breuer
Aug 10, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Toulmonde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

© 2021 Meta ULC. All rights reserved